Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × oblimersen × Clear all

NCT00005032 2013-02-11

Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 1/2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma